Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against TransMedics Group, Inc. (TMDX) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / September 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain […]

Bronstein, Gewirtz & Grossman, LLC Encourages Civitas Resources, Inc. (CIVI) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / September 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Civitas Resources, Inc. ("Civitas" or "the Company") (NYSE:CIVI). Investors who purchased Civitas securities prior to February 27, 2024, and continue to hold to the present, are encouraged to obtain

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / September 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") (NASDAQ:MRVI). Investors who purchased Maravai securities prior to August 7, 2024, and continue to hold to the present, are encouraged to

Bronstein, Gewirtz & Grossman, LLC Encourages Nextracker Inc. (NXT) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / September 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nextracker Inc. ("Nextracker" or "the Company") (NASDAQ:NXT). Investors who purchased Nextracker securities prior to February 1, 2024, and continue to hold to the present, are encouraged to obtain additional

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / September 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ:LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to obtain additional

Bronstein, Gewirtz & Grossman, LLC Encourages America’s Car-Mart, Inc. (CRMT) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / September 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of America’s Car-Mart, Inc. ("Car-Mart" or "the Company") (NASDAQ:CRMT). Investors who purchased Car-Mart securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/CRMT.

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against ASP Isotopes Inc. (ASPI) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / September 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ASP Isotopes Inc. ("ASP Isotopes" or "the Company") (NASDAQ:ASPI). Investors who purchased ASP Isotopes securities prior to October 30, 2024, and continue to hold to the present, are encouraged

Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / September 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Treace Medical Concepts, Inc. ("Treace Medical" or "the Company") (NASDAQ:TMCI). Investors who purchased Treace Medical securities prior to May 8, 2023, and continue to hold to the present, are

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Atkore Inc. (ATKR) and Encourages Stockholders to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / September 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atkore Inc. ("Atkore" or "the Company") (NYSE:ATKR). Investors who purchased Atkore securities prior to August 2, 2022, and continue to hold to the present, are encouraged to obtain additional

Bronstein, Gewirtz & Grossman, LLC Encourages Ultra Clean Holdings, Inc. (UCTT) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / September 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ultra Clean Holdings, Inc. ("Ultra Clean" or "the Company") (NASDAQ:UCTT). Investors who purchased Ultra Clean securities prior to May 6, 2024, and continue to hold to the present, are

Scroll to Top